Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c
Tweet
Share
E-mailGet Alerts DFTX Hot Sheet
Join SI Premium – FREE
Definium Therapeutics, Inc. (NASDAQ: DFTX) reported Q1 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Definium Therapeutics, Inc. (DFTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
- Nomura/Instinet Reiterates Buy Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
- Morgan Stanley Starts Jersey Mike's Subs (JMKE) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
